Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Biomarker Analysis of Patients With Metastatic Castration-resistant Prostate Cancer (mCRPC) Undergoing Bipolar Androgen Therapy (BAT)

NCT04424654 is registered in ClinicalTrials.gov with Hospital Sirio-Libanes as lead sponsor.

NCT NCT04424654
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04424654 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Biomarker Analysis of Patients With Metastatic Castration-resistant Prostate Cancer (mCRPC) Undergoing Bipolar Androgen Therapy (BAT)
Lead sponsor
Hospital Sirio-Libanes
Phase
Phase 2
Overall status
Completed
Start date
September 22, 2020
Completion date
July 1, 2022
Enrollment
20 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer